• Loading stock data…

BeiGene Announces Acceptance of a Supplemental New Drug Application in China for BRUKINSA (zanubrutinib) in Waldenström’s Macroglobulinemia

[#item_full_content]

Print Friendly, PDF & Email
Spread the word